在日本普通人群中 U-ACE2 和 P-ACE2（尿和血浆血管紧张素转换酶 2）的不同调节。
Distinct Regulation of U-ACE2 and P-ACE2 (Urinary and Plasma Angiotensin-Converting Enzyme 2) in a Japanese General Population.
机构信息
Department of Cardiovascular, Renal and Metabolic Medicine (M.F., A.S., M.T., Y.H., K.M., M.K., H.O., S.S.), Sapporo Medical University School of Medicine, Japan.
Department of Public Health (M.K., H.O.), Sapporo Medical University School of Medicine, Japan.
出版信息
Hypertension. 2021 Sep;78(4):1138-1149. doi: 10.1161/HYPERTENSIONAHA.121.17674. Epub 2021 Aug 23.
Abstract
[Figure: see text].
摘要
[图：见正文]。
相似文献
1
Distinct Regulation of U-ACE2 and P-ACE2 (Urinary and Plasma Angiotensin-Converting Enzyme 2) in a Japanese General Population.
Hypertension. 2021 Sep;78(4):1138-1149. doi: 10.1161/HYPERTENSIONAHA.121.17674. Epub 2021 Aug 23.
2
Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication?
Sci China Life Sci. 2020 Nov;63(11):1766-1767. doi: 10.1007/s11427-020-1759-4. Epub 2020 Jun 24.
3
Role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19.
Biomark Med. 2021 Dec;15(17):1581-1588. doi: 10.2217/bmm-2021-0121. Epub 2021 Oct 27.
4
Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.
Front Immunol. 2021 Jun 14;12:625732. doi: 10.3389/fimmu.2021.625732. eCollection 2021.
5
Plasma ACE2 species are differentially altered in COVID-19 patients.
FASEB J. 2021 Aug;35(8):e21745. doi: 10.1096/fj.202100051R.
6
SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19.
Int J Mol Sci. 2021 Apr 25;22(9):4472. doi: 10.3390/ijms22094472.
7
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
Hypertension. 2022 Feb;79(2):365-378. doi: 10.1161/HYPERTENSIONAHA.121.18295. Epub 2021 Nov 30.
8
Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes.
Life Sci. 2022 Mar 15;293:120324. doi: 10.1016/j.lfs.2022.120324. Epub 2022 Jan 12.
9
Reduction in ACE2 expression in peripheral blood mononuclear cells during COVID-19 - implications for post COVID-19 conditions.
BMC Infect Dis. 2024 Jul 3;24(1):663. doi: 10.1186/s12879-024-09321-0.
10
Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease.
J Cell Mol Med. 2021 Apr;25(8):3840-3855. doi: 10.1111/jcmm.16310. Epub 2021 Mar 4.
引用本文的文献
1
Expression of SARS-CoV-2 entry receptor ACE2 in human brain and its association with Alzheimer's disease and COVID-19.
Mol Psychiatry. 2025 Apr 6. doi: 10.1038/s41380-025-03006-z.
2
Shared genetics and causal association between plasma levels of SARS-CoV-2 entry receptor ACE2 and Alzheimer's disease.
CNS Neurosci Ther. 2024 Jul;30(7):e14873. doi: 10.1111/cns.14873.
3
Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury.
Clin Kidney J. 2022 Sep 21;16(2):272-284. doi: 10.1093/ckj/sfac215. eCollection 2023 Feb.
4
Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19.
PLoS One. 2023 Jan 12;18(1):e0280280. doi: 10.1371/journal.pone.0280280. eCollection 2023.
5
Angiotensin-converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID-19 severity in Iranian population.
Int J Immunogenet. 2022 Oct;49(5):325-332. doi: 10.1111/iji.12598. Epub 2022 Aug 27.
本文引用的文献
1
Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.
Cell. 2021 Apr 15;184(8):2212-2228.e12. doi: 10.1016/j.cell.2021.02.053. Epub 2021 Mar 2.
2
Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.
J Clin Med. 2021 Feb 11;10(4):702. doi: 10.3390/jcm10040702.
3
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.
JAMA. 2021 Jan 19;325(3):254-264. doi: 10.1001/jama.2020.25864.
4
Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.
Lancet Respir Med. 2021 Mar;9(3):275-284. doi: 10.1016/S2213-2600(20)30558-0. Epub 2021 Jan 7.
5
ACE2: from protection of liver disease to propagation of COVID-19.
Clin Sci (Lond). 2020 Dec 11;134(23):3137-3158. doi: 10.1042/CS20201268.
6
Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.
Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H296-H304. doi: 10.1152/ajpheart.00755.2020. Epub 2020 Dec 4.
7
Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
Am J Hypertens. 2021 Apr 2;34(3):278-281. doi: 10.1093/ajh/hpaa169.
8
Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis.
Lancet. 2020 Oct 3;396(10256):968-976. doi: 10.1016/S0140-6736(20)31964-4.
9
Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study.
J Infect. 2020 Nov;81(5):e3-e5. doi: 10.1016/j.jinf.2020.08.052. Epub 2020 Sep 10.
10
U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2.
Hypertens Res. 2021 Jan;44(1):107-116. doi: 10.1038/s41440-020-0532-z. Epub 2020 Aug 13.
Zotero 插件